Identification and Characterisation of Infectious Disease Risks of Human Cells, Tissues, and Cellular- and Tissue-based Products


8 February, Workshop, Maryland, USA

The USA Food and Drug Administration (FDA) is running a public workshop to have a scientific discussion of the current methods available for identifying and characterising infectious disease risks associated with human cells, tissues, and cellular and tissue-based products (HCT/Ps).

For more details email Monica Kapoor or Stacey Rivette at the Center for Biologics Evaluation and Research, FDA with the subject line titled “HCT/P Workshop.”

Organiser: FDA